Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases

被引：1

作者：

Imazio, Massimo ^{[1
,2
]}

Collini, Valentino ^{[2
]}

Aimo, Alberto ^{[3
]}

Autore, Camillo ^{[4
]}

Bauce, Barbara ^{[5
]}

Biagini, Elena ^{[6
]}

Cappelli, Francesco ^{[7
]}

Castelletti, Silvia ^{[8
]}

D'Ascenzi, Flavio ^{[9
]}

De Gregorio, Cesare ^{[10
]}

Limongelli, Giuseppe ^{[11
]}

Marzo, Francesca ^{[12
]}

Merlo, Marco ^{[13
,14
]}

Musumeci, Beatrice ^{[4
]}

Paolillo, Stefania ^{[15
]}

Tini, Giacomo ^{[3
]}

Pedrinelli, Roberto ^{[16
]}

Filardi, Pasquale Perrone ^{[15
]}

Sinagra, Gianfranco ^{[13
,14
]}

机构：

[1] Univ Udine, Dept Med DMED, Udine, Italy

[2] Univ Hosp Santa Maria Misericordia, Clin Neurol Unit, Udine, Italy

[3] Fdn Monasterio & Scuola Super St Anna, Pisa, Italy

[4] Sapienza Univ, Dept Clin & Mol Med, Rome, Italy

[5] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy

[6] IRCSS Azienda Osped Univ Bologna, Cardiol Unit, Bologna, Italy

[7] Careggi Univ Hosp, Tuscan Reg Amyloidosis Ctr, Florence, Italy

[8] IRCCS Ist Auxol Italiano, Dept Neurol, Milan, Italy

[9] Univ Siena, Dept Med Biotechnol, Div Cardiol, Siena, Italy

[10] Univ Hosp Messina, Dept Clin & Expt Med, Messina, Italy

[11] Univ Campania Luigi Vanvitelli, Monaldi Hosp, Dept Translat Med Sci, Inherited & Rare Cardiovasc Dis, Naples, Italy

[12] Infermi Hosp, Cardiol Unit, Rimini, Italy

[13] Azienda Sanit Univ Giuliano Isontina, Cardiovasc Dept, Trieste, Italy

[14] Univ Trieste, Trieste, Italy

[15] Federico II Univ Naples, Italian Soc Cardiol, Dept Adv Biomed Sci, Naples, Italy

[16] Univ Pisa, Cardiac Thorac & Vasc Dept, Pisa, Italy

来源：

JOURNAL OF CARDIOVASCULAR MEDICINE | 2025年 / 26卷 / 01期

关键词：

constrictive pericarditis; diagnosis; multimodality imaging; pericardial effusion; pericarditis; therapy; RECURRENT PERICARDITIS; EUROPEAN-SOCIETY; MANAGEMENT; COLCHICINE; CORTICOSTEROIDS; PREVALENCE; GUIDELINES; THERAPY;

D O I：

10.2459/JCM.0000000000001684

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The knowledge of pericardial diseases has now improved, including prospective and retrospective cohort studies focusing on the pathogenesis, diagnosis, treatment, and outcomes. The complex interplay between genetic predisposition (especially for autoinflammatory conditions), inflammation, and autoimmunity is now known to trigger recurrences of pericarditis. Moreover, diagnostic capabilities have improved with the implementation of multimodality imaging, particularly cardiac magnetic resonance (CMR), to detect and monitor pericardial inflammation, to allow diagnosis in more complicated cases, and tailor the duration of therapy based on objective parameters. A new class of drugs, the anti-IL-1 agents, have been introduced for patients with an inflammatory phenotype of presentation, and not responding to conventional anti-inflammatory therapies, including NSAID, colchicine, and corticosteroids. At present, the clinical management of pericardial diseases is definitely on the road of evidence-based medicine with new ongoing European guidelines focusing on the spectrum of inflammatory myocardial and pericardial syndromes.

引用

页码：29 / 37

页数：9